Working with Professor Jillian Kohler, PharmSci MSc student Ariel Gorodensky is studying the equitable distribution of COVID-19 vaccines around the world.

Andrew Toye Ojo, a recent PhD graduate from U of T’s Leslie Dan Faculty of Pharmacy, is impacting patient care with his advanced knowledge of pharmaceutical sciences and a career in health care consulting.

The Collaborative Specialization in Next-Generation Precision Medicine opened for enrolment this week and will offer courses this fall at the Leslie Dan Faculty of Pharmacy, the Temerty Faculty of Medicine, the Faculty of Arts & Science and the Faculty of Applied Science and Engineering.

Stéphane Angers’ lab and collaborators develop an antibody drug that can restore function of blood-retina barrier

Hanie Yousefi reflects on her experience participating in U of T's Three Minute Thesis Competition, and the art of communicating the essence of one's research.

Four students from the Leslie Dan Faculty of Pharmacy are being honoured with the U of T’s 2021 Student Leadership Awards.

Researchers have developed a new nanoparticle that can help diagnose and intervene in Alzheimer’s disease at an early stage by enabling MRI to image early changes in the brain before symptoms of the disease occur.

Professor Raymond Reilly's Lab developed a radiopharmaceutical that's helping an interdisciplinary research team at Sunnybrook visualize the uptake of Herceptin in brain metastases from breast cancer.

PRiME is hosting a virtual showcase on February 17 about how Canadian biotech hubs can transform health care and drive post-pandemic economic recovery.

PharmSci alumna Béatrice Séguin shares her journey from think tank to co-founder and Chief Innovation Officer of MOB Beauty on the International Day of Women and Girls in Science.

PhD candidate Sana-Kay Whyte-Allman discusses challenges she's overcame throughout her research, how becoming a mother during her PhD studies taught her resilience and determination, and her advice to women in the BIOPC community who are considering pursuing pharmaceutical sciences.

Evan Amalfitano and Keith Pardee developed a point-of-care diagnostic test using a widely available glucose meter that can be adapted to diagnose a number of diseases, including COVID-19.